Summary
Using a sensitive infant mouse bioassay to detect infectious virus, the pattern of mouse hepatitis virus (MHV) JHM dissemination in blood and other tissues was examined during the first 5 days following intranasal inoculation. MHV replicated in nasal turbinates of both susceptible BALB and resistant SJL mice from days 1 through 5, but BALB mice had higher titers on days 1 and 2. Viremia was detectable on days 1 through 5 in BALB mice, but only on days 3 and 5 in SJL mice. Transient virus replication occurred in the lungs of both mouse genotypes at 1 and 2 days, then ceased. This correlated with more consistently demonstrable virus in blood collected from the left atrium of the heart, compared to jugular vein, portal vein and right atrial blood. Virus was associated equally with the plasma and cellular fractions of blood on day 3, but was primarily in the buffy coat of the cellular fraction on day 5. Interferon-α/β was detected in serum and spleen, but not liver or brain of BALB mice or in any tissue of SJL mice. BALB serum and spleen interferon was first detected at 36h, peaked between 48 and 72h, and was undetectable by 108h. The distribution of virus in nose, cervical, axillary and mesenteric lymph nodes, spleen, Peyer's patch, thymus, bone marrow and liver was examined at 1, 2, and 3 days. The resulting pattern suggested lymphatic spread of virus to cervical lymph node and mesenteric lymph node as pathways of dissemination in addition to viremia.
Article PDF
Similar content being viewed by others
References
Barthold SW (1986) Mouse hepatitis virus biology and epizootiology. In: Bhatt PN, Jacoby RO, Morse AC III, New AE (eds) Viral and mycoplasmal infections of laboratory rodents: effects on biomedical research. Academic Press, Orlando, FL, pp 571–601
Barthold SW (1988) Olfactory neural pathway in mouse hepatitis virus nasoencephalitis. Acta Neuropathol 76: 502–506
Barthold SW, de Souza MS, Smith AL (1990) Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species. Lab Anim Sci 40: 481–485
Barthold SW, Smith AL (1984) Mouse hepatitis virus strain-related patterns of tissue tropism in suckling mice. Arch Virol 81: 103–112
Barthold SW, Smith AL (1987) Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis viurs JHM. Virus Res 7: 225–239
Boyle JF, Weismiller DG, Holmes KV (1987) Genetic resistance of MHV correlates with absence of virus-binding activity on target tissues. J Virol 61: 185–189
Furuta T, Goto Y, Tamura T, Kai C, Ueda K (1979) Pulmonary vascular lesions in nude mice persistently infected with mouse hepatitis virus. Japan J Exp Med 49: 423–428
Garlinghouse LE, Smith AL (1985) Responses of mice susceptible or resistant to lethal infection with mouse hepatitis virus, strain JHM, after exposure by a natural route. Lab Anim Sci 35: 469–472
Goto N, Hirano N, Aiuchi M, Hayashi T, Fujiwara K (1977) Nasoencephalopathy of mice infected intranasally with a mouse hepatitis virus, JHM strain. Japan J Exp Med 47: 59–70
Knobler RL, Oldstone MBA (1986) Infection and involution of mouse thymus by MHV-4. Adv Exp Med Biol 218: 451–453
Lavelle GC, Starr TJ (1968) Effects of cortisone on interferon response of germfree mice to mouse hepatitis virus. J Reticuloend Soc 5: 436–444
Lavi E, Gilden DH, Highkin MK, Weiss SR (1984) MHV-A59 pathogenesis in mice. Adv Exp Med Biol 173: 237–245
Le Prevost C, Levy-Leblond E, Virelizier J, Dupuy J (1975) Immunopathology of mouse hepatitis virus type 3 infection. I. Role of humoral and cell-mediated immunity in resistance mechanisms. J Immunol 114: 221–225
Piazza M, Pane G, DeRitis F (1967) The fate of murine hepatitis virus (MHV-3) after intravenous injection into susceptible mice. Arch Ges Virusforsch 22: 472–474
Rubinstein S, Familletti PC, Pestka S (1981) Convenient assay for interferons. J Virol 37: 755–758
Schindler L, Engler H, Kirschner H (1982) Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice. Infect Immun 35: 869–873
Smith AL, Winograd DF (1986) Two enzyme immunoassays for the detection of antibody to rodent coronoaviruses. J Virol Methods 14: 335–343
Taguchi F, Goto Y, Aiuchi M, Hayashi T, Fujiwara K (1979) Pathogenesis of mouse hepatitis virus infection. The role of nasal epithelial cells as a primary target of low-virulence virus, MHV-S. Microbiol Immunol 23: 249–262
Taguchi F, Hirano N, Kiuchi Y, Fujiwara K (1976) Difference in response to mouse hepatitis virus among susceptible mouse strains. Japan J Exp Med 20: 293–302
Taguchi F, Siddell SG (1985) Difference in sensitivity to interferon among mouse hepatitis viruses with high and low virulence for mice. Virology 147: 41–48
Taguchi F, Yamada A, Fujiwara K (1979) Factors involved in the age-dependent resistance of mice infected with low virulence mouse hepatitis virus. Arch Virol 62: 333–340
Virelizier JL, Virelizier AM, Allison AC (1976) The role of circulating interferon in the modifications of immune responsiveness by mouse hepatitis virus (MHV-3). J Immunol 117: 748–753
Wege H, Siddell S, ter Meulen V (1982) The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol 99: 165–200
Williams RF, Jiang G-S, Snyder SW, Frana WF, Holmes KV (1990) Purification of the 110-kilodalton glycoprotein receptor for MHV (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J Virol 64: 3817–3823
Yamada Y, Taguchi F, Fujiwara K (1979) T-lymphocyte.dependent difference in susceptibility between DDD and C3H mice to mouse hepatitis virus, MHV-3. Japan J Exp Med 49: 413–421
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barthold, S.W., Smith, A.L. Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice. Archives of Virology 122, 35–44 (1992). https://doi.org/10.1007/BF01321116
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01321116